Investment
Features
FeesSafety
Academy
More
Pluang+

Gold holds steady near $4,300 amid resilient US manufacturing data and possible Fed rate hikes.

Market News
25 Sep 2026
Kitco
View Source
Neutral
Gold holds steady near $4,300 amid resilient US manufacturing data and possible Fed rate hikes.

Gold prices remain stable around $4,300 an ounce despite stronger-than-expected US durable goods orders in August, signaling resilience in the manufacturing sector. Core durable goods and non-defense capital goods orders rose modestly, suggesting economic strength that could prompt the Federal Reserve to continue tightening interest rates to combat inflation. This dynamic creates headwinds for gold, which typically struggles when rates rise. Investors are watching closely as the Fed's actions will influence gold's near-term direction.

Gold prices holding steady around $4,300 an ounce provide context for this report on US durable goods. For readers following US stocks on Pluang as of Sep 25, 2026 19:11 WIB, 100 of 150 priced US stocks rose while 46 fell. Notable movers include Unity Software Inc (U) at USD 40.64 with a 1-day change of -1.88% and 100% buy order activity, Applied Materials, Inc. (AMAT) at USD 483.10 up 1.87% with 87% sell order activity, and JetBlue Airways Corporation (JBLU) at USD 4.43 up 1.84%.

More News

Oklo advances SMR tech and plans first microreactors by 2028 with UBS target at $41.

Oklo advances SMR tech and plans first microreactors by 2028 with UBS target at $41.

Oklo, a pre-revenue nuclear tech company, is developing advanced small modular reactors (SMRs) called Aurora Powerhouses aimed at clean energy for data centers. UBS set a price target of $41, indicating a 7.08% upside from the current $38.29 stock pr...

Market News
Bullish
2 hours ago
Barclays rates Ligand Pharmaceuticals 'Overweight' with $345 target on royalty growth.

Barclays rates Ligand Pharmaceuticals 'Overweight' with $345 target on royalty growth.

Barclays initiated coverage on Ligand Pharmaceuticals with an 'Overweight' rating and set a price target of $345, implying a 15.37% upside from its current price. The biopharma company is expanding its royalty portfolio through investments in cancer ...

Analyst Insights
Bullish
3 hours ago
Nike stock falls as Bank of America delays its recovery by a year, while rivals hold steady.

Nike stock falls as Bank of America delays its recovery by a year, while rivals hold steady.

Bank of America downgraded Nike to Underperform and cut its price target to $30, citing a delayed sales recovery now expected a full fiscal year later. The bank highlighted risks including slowing North America wholesale, weak demand in China, produc...

Market News
Bearish
4 hours ago
New Jersey American Water highlights efforts to protect water sources during Source Water Protection Week.

New Jersey American Water highlights efforts to protect water sources during Source Water Protection Week.

New Jersey American Water is emphasizing the importance of protecting natural water sources during the American Water Works Association's Source Water Protection Week from Sept. 27 to Oct. 3. The company collaborates with local partners to safeguard ...

Market News
Neutral
4 hours ago
US-China trade truce extended; soybean gains contrast with stagnant chip sector outlook.

US-China trade truce extended; soybean gains contrast with stagnant chip sector outlook.

The US and China have extended their trade truce by two months, focusing on farm goods like soybeans while largely sidelining semiconductors. China is meeting soybean purchase commitments, benefiting companies like Archer-Daniels-Midland and Bunge, b...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App